BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23948221)

  • 21. CPAP treatment of a population-based sample--what are the benefits and the treatment compliance?
    Lindberg E; Berne C; Elmasry A; Hedner J; Janson C
    Sleep Med; 2006 Oct; 7(7):553-60. PubMed ID: 16740408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of speech therapy as adjunct treatment to continuous positive airway pressure on the quality of life of patients with obstructive sleep apnea.
    Diaferia G; Badke L; Santos-Silva R; Bommarito S; Tufik S; Bittencourt L
    Sleep Med; 2013 Jul; 14(7):628-35. PubMed ID: 23702236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of CPAP treatment in a sleep laboratory specialized in neuropsychiatry.
    Antczak J; Geisler P; Popp R
    J Physiol Pharmacol; 2004 Sep; 55 Suppl 3():15-22. PubMed ID: 15611589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The characteristics and determining factors of attention and short-term memory impairment in young patients with obstructive sleep apnea-hypopnea syndrome].
    Li Q; Li NZ; Li TT; Sun YQ; Wang J; Chen R
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):419-425. PubMed ID: 31189227
    [No Abstract]   [Full Text] [Related]  

  • 25. Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure.
    Morisson F; Décary A; Petit D; Lavigne G; Malo J; Montplaisir J
    Chest; 2001 Jan; 119(1):45-52. PubMed ID: 11157583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Short-term and long-term influences of nasal continuous positive airway pressure to sleep architecture of obstructive sleep apnea hypopnea syndrome].
    Xiao YL; Richter F; Brunner F; Lerche B; Zhang DP; Zheng PD
    Zhonghua Nei Ke Za Zhi; 2004 Sep; 43(9):651-3. PubMed ID: 15500774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-choice treatment in mild to moderate obstructive sleep apnea: single-stage, multilevel, temperature-controlled radiofrequency tissue volume reduction or nasal continuous positive airway pressure.
    Ceylan K; Emir H; Kizilkaya Z; Tastan E; Yavanoglu A; Uzunkulaoglu H; Samim E; Felek SA
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):915-9. PubMed ID: 19770425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response shift in perception of sleepiness in obstructive sleep apnea-hypopnea syndrome before and after treatment with nasal CPAP.
    Chin K; Fukuhara S; Takahashi K; Sumi K; Nakamura T; Matsumoto H; Niimi A; Hattori N; Mishima M; Nakamura T
    Sleep; 2004 May; 27(3):490-3. PubMed ID: 15164904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome.
    Sugiura T; Noda A; Nakata S; Yasuda Y; Soga T; Miyata S; Nakai S; Koike Y
    Respiration; 2007; 74(1):56-60. PubMed ID: 16299414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of improvements in daytime function outcomes with CPAP therapy.
    Kingshott RN; Vennelle M; Hoy CJ; Engleman HM; Deary IJ; Douglas NJ
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):866-71. PubMed ID: 10712335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome.
    Bonsignore MR; Parati G; Insalaco G; Marrone O; Castiglioni P; Romano S; Di Rienzo M; Mancia G; Bonsignore G
    Am J Respir Crit Care Med; 2002 Aug; 166(3):279-86. PubMed ID: 12153958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term evolution of daytime somnolence in patients with sleep apnea/hypopnea syndrome treated by continuous positive airway pressure.
    Meurice JC; Paquereau J; Neau JP; Caron F; Dore P; Ingrand P; Patte F
    Sleep; 1997 Dec; 20(12):1162-6. PubMed ID: 9493927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].
    Sun L; Chen R; Wang J; Zhang Y; Li J; Peng W; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3483-7. PubMed ID: 25622738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial response of blood pressure to short-term continuous positive airway pressure in Chinese patients with obstructive sleep apnea-hypopnea syndrome.
    Wang X; Qiu J; Wang Y; Cai Z; Lu X; Li T
    Blood Press Monit; 2018 Aug; 23(4):175-184. PubMed ID: 29746310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea.
    Ruttanaumpawan P; Gilman MP; Usui K; Floras JS; Bradley TD
    J Hypertens; 2008 Jun; 26(6):1163-8. PubMed ID: 18475154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Residual excessive daytime sleepiness in CPAP-treated obstructive sleep apnea].
    Buffle C; Gex G; Cervena K ; Younossian AB; Adler D
    Rev Med Suisse; 2014 Nov; 10(451):2214-8. PubMed ID: 25603569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of short-term CPAP withdrawal on neurobehavioral performance in patients with obstructive sleep apnea.
    Yang Q; Phillips CL; Melehan KL; Rogers NL; Seale JP; Grunstein RR
    Sleep; 2006 Apr; 29(4):545-52. PubMed ID: 16676788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive recovery following positive airway pressure (PAP) in sleep apnea.
    Matthews EE; Aloia MS
    Prog Brain Res; 2011; 190():71-88. PubMed ID: 21531245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome.
    Noda A; Nakata S; Koike Y; Miyata S; Kitaichi K; Nishizawa T; Nagata K; Yasuma F; Murohara T; Yokota M
    Hypertens Res; 2007 Aug; 30(8):669-76. PubMed ID: 17917313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.